Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRS A-Fib Ablation Consensus Statement Offers Clinical Trial Advice

This article was originally published in The Gray Sheet

Executive Summary

A new expert 1consensus statement on ablation of atrial fibrillation, created by a Heart Rhythm Society task force, includes 21 specific recommendations for the design and conduct of clinical trials of AF ablation devices
Advertisement

Related Content

AF Ablation Attracts Stronger Support In Updated Clinical Guidelines
FDA, Cardiac Safety Research Consortium To Develop AF Ablation Registry
Experts Discuss Lessons From A-Fib Ablation Trials At Boston Meeting
People In Brief
AF Ablation Devices Need Randomized Trials, Advisory Panel Tells FDA
Corrections
FDA Dispute Panel Rebuffs Cardima’s Catheter A-Fib Claims
Catheter Ablation “Reasonable” For Atrial Fibrillation When Drugs Fail - ACC
FDA Considers Easing Industry Burden In AF Ablation Catheter Trial Design
FDA Considers Easing Industry Burden In AF Ablation Catheter Trial Design
Advertisement
UsernamePublicRestriction

Register

MT024793

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel